[1]
2026. Artificial Intelligence and Multi-Omics for Anticancer Drug Development and Repurposing: Review article. Journal of Pharma Insights and Research. 4, 2 (Apr. 2026), 001–008. DOI:https://doi.org/10.69613/fyreqa27.